As of 2025-10-19, the Relative Valuation of CTC Bio Inc (060590.KQ) is (440.59) KRW. This relative valuation is based on P/E multiples. With the latest stock price at 5,280.00 KRW, the upside of CTC Bio Inc based on Relative Valuation is -108.3%.
The range of the Relative Valuation is (422.26) - (497.69) KRW.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.0x - 15.2x | 14.0x |
| Forward P/E multiples | 8.9x - 14.1x | 11.0x |
| Fair Price | (422.26) - (497.69) | (440.59) |
| Upside | -108.0% - -109.4% | -108.3% |
| Date | P/E |
| 2025-10-17 | -149.80 |
| 2025-10-16 | -153.77 |
| 2025-10-15 | -154.62 |
| 2025-10-14 | -155.19 |
| 2025-10-13 | -160.30 |
| 2025-10-10 | -163.42 |
| 2025-10-02 | -168.52 |
| 2025-10-01 | -171.64 |
| 2025-09-30 | -174.77 |
| 2025-09-29 | -176.75 |
| 2025-09-26 | -192.92 |
| 2025-09-25 | -198.03 |
| 2025-09-24 | -197.75 |
| 2025-09-23 | -200.30 |
| 2025-09-22 | -202.00 |
| 2025-09-19 | -203.14 |
| 2025-09-18 | -203.14 |
| 2025-09-17 | -203.14 |
| 2025-09-16 | -207.68 |
| 2025-09-15 | -207.68 |
| 2025-09-12 | -211.36 |
| 2025-09-11 | -198.31 |
| 2025-09-10 | -201.43 |
| 2025-09-09 | -200.87 |
| 2025-09-08 | -202.29 |
| 2025-09-05 | -200.30 |
| 2025-09-04 | -199.45 |
| 2025-09-03 | -200.58 |
| 2025-09-02 | -192.07 |
| 2025-09-01 | -188.10 |
| 2025-08-29 | -189.80 |
| 2025-08-28 | -189.23 |
| 2025-08-27 | -190.37 |
| 2025-08-26 | -189.52 |
| 2025-08-25 | -191.22 |
| 2025-08-22 | -188.95 |
| 2025-08-21 | -180.16 |
| 2025-08-20 | -179.59 |
| 2025-08-19 | -183.56 |
| 2025-08-18 | -187.25 |
| 2025-08-14 | -190.37 |
| 2025-08-13 | -190.09 |
| 2025-08-12 | -180.16 |
| 2025-08-11 | -175.90 |
| 2025-08-08 | -175.90 |
| 2025-08-07 | -175.05 |
| 2025-08-06 | -175.05 |
| 2025-08-05 | -173.63 |
| 2025-08-04 | -171.93 |
| 2025-08-01 | -171.36 |